A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated
- PMID: 7908440
- PMCID: PMC43437
- DOI: 10.1073/pnas.91.7.2699
A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated
Abstract
The beta 2-adrenergic receptor (beta 2AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant beta 2AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (Gs)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant beta AR-specific kinase (beta ARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates Gs protein and is identical to the beta ARK substrate.
Similar articles
-
Role of beta ARK in long-term agonist-promoted desensitisation of the beta 2-adrenergic receptor.Cell Signal. 1998 Mar;10(3):197-204. doi: 10.1016/s0898-6568(97)00112-5. Cell Signal. 1998. PMID: 9607143
-
Stable association of G proteins with beta 2AR is independent of the state of receptor activation.Cell Signal. 1999 Jul;11(7):523-33. doi: 10.1016/s0898-6568(99)00024-8. Cell Signal. 1999. PMID: 10405763
-
Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.Biochemistry. 1994 Aug 16;33(32):9414-9. doi: 10.1021/bi00198a006. Biochemistry. 1994. PMID: 7915137
-
Inverse agonism and the regulation of receptor number.Trends Pharmacol Sci. 1997 Dec;18(12):468-74. doi: 10.1016/s0165-6147(97)01139-5. Trends Pharmacol Sci. 1997. PMID: 9458695 Review.
-
Molecular and genetic basis of beta2-adrenergic receptor function.J Allergy Clin Immunol. 1999 Aug;104(2 Pt 2):S42-6. doi: 10.1016/s0091-6749(99)70272-1. J Allergy Clin Immunol. 1999. PMID: 10452787 Review.
Cited by
-
Beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle.Br J Pharmacol. 2000 Nov;131(5):915-20. doi: 10.1038/sj.bjp.0703664. Br J Pharmacol. 2000. PMID: 11053211 Free PMC article.
-
Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.Mol Neurobiol. 1998 Winter;17(1-3):109-35. doi: 10.1007/BF02802027. Mol Neurobiol. 1998. PMID: 9887449 Review.
-
Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.J Pharmacol Exp Ther. 2016 Dec;359(3):411-419. doi: 10.1124/jpet.116.232835. Epub 2016 Sep 22. J Pharmacol Exp Ther. 2016. PMID: 27660244 Free PMC article.
-
Neurofilament-M interacts with the D1 dopamine receptor to regulate cell surface expression and desensitization.J Neurosci. 2002 Jul 15;22(14):5920-30. doi: 10.1523/JNEUROSCI.22-14-05920.2002. J Neurosci. 2002. PMID: 12122054 Free PMC article.
-
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.Int J Neuropsychopharmacol. 2018 Oct 1;21(10):962-977. doi: 10.1093/ijnp/pyy071. Int J Neuropsychopharmacol. 2018. PMID: 30085126 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials